The treatment landscape for Cushing's syndrome has advanced significantly over the past decade. Physicians now have multiple medical therapies capable of reducing the effects of excess cortisol, while surgical techniques continue to improve outcomes for appropriately selected patients. Yet despite these advances, one of the largest unmet needs in endocrinology remains unchanged. Patients are still diagnosed far too late. This article is not about comparing therapies or recommending one treatment…
Full article
Full article available by request only.
Contact PharmaKonsult to request the complete opinion paper.